These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6734042)

  • 1. Electroencephalographic and behavioral correlates of buprenorphine administration.
    Lukas SE; Jasinski DR; Johnson RE
    Clin Pharmacol Ther; 1984 Jul; 36(1):127-32. PubMed ID: 6734042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine suppresses heroin use by heroin addicts.
    Mello NK; Mendelson JH
    Science; 1980 Feb; 207(4431):657-9. PubMed ID: 7352279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of buprenorphine and methadone effects on opiate self-administration in primates.
    Mello NK; Bree MP; Mendelson JH
    J Pharmacol Exp Ther; 1983 May; 225(2):378-86. PubMed ID: 6188822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral pharmacology of buprenorphine.
    Mello NK; Mendelson JH
    Drug Alcohol Depend; 1985 Feb; 14(3-4):283-303. PubMed ID: 3888577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients.
    Dunn KE; Finan PH; Andrew Tompkins D; Strain EC
    Addict Behav; 2018 Jan; 76():8-14. PubMed ID: 28735039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.
    Johnson RE; Chutuape MA; Strain EC; Walsh SL; Stitzer ML; Bigelow GE
    N Engl J Med; 2000 Nov; 343(18):1290-7. PubMed ID: 11058673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI; Burt R; Thiede H; Glick SN
    Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
    Curcio F; Franco T; Topa M; Baldassarre C;
    Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Ohlmeier M; Passie T; Hauser U; Becker H; Wiese B; Emrich H; Schneider U
    Addict Biol; 2005 Jun; 10(2):157-64. PubMed ID: 16191668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone.
    Strain EC; Preston KL; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1995 Feb; 272(2):628-38. PubMed ID: 7853176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone.
    Jones HE; Johnson RE; Jasinski DR; Milio L
    Drug Alcohol Depend; 2005 Apr; 78(1):33-8. PubMed ID: 15769555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine for cocaine and opiate dependence.
    Kosten TR; Rosen MI; Schottenfeld R; Ziedonis D
    Psychopharmacol Bull; 1992; 28(1):15-9. PubMed ID: 1609037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.
    Rosado J; Walsh SL; Bigelow GE; Strain EC
    Drug Alcohol Depend; 2007 Oct; 90(2-3):261-9. PubMed ID: 17517480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.
    Marsch LA; Stephens MA; Mudric T; Strain EC; Bigelow GE; Johnson RE
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):293-302. PubMed ID: 16366759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Males and females differ in response to opioid agonist medications.
    Jones HE; Fitzgerald H; Johnson RE
    Am J Addict; 2005; 14(3):223-33. PubMed ID: 16019973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of buprenorphine and methadone in the treatment of opioid dependence.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    Am J Psychiatry; 1994 Jul; 151(7):1025-30. PubMed ID: 8010359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.